[Skip to Content]
Navigation
Home > Medical Directory > Scleroderma Symptoms > Lung Involvement

Lung (Pulmonary) Overview

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer
Overview
Symptoms
Diagnosis
Severity and Prognosis
Aspiration Pneumonia
Autoimmune Interstitial Pneumonia
Lung Cancer
Methotrexate Lung Complications
Pleural Effusion
Pulmonary Fibrosis
Pulmonary Hypertension
Pulmonary Veno-Occlusive Disease
Restrictive Lung Disease
Shrinking Lung Syndrome
Oxygen Therapy
Personal Stories

Overview of Scleroderma Lung Involvement

Systemic sclerosis (scleroderma) can affect the skin and/or internal organs. One of the ways scleroderma can affect the lungs is by causing pulmonary fibrosis, which is a scarring of the lungs. Lung involvement is the second most common complication of systemic scleroderma, eventually occurring in about 70%, and, unfortunately, it is the most common cause of death.
Systemic sclerosis (scleroderma)—such as limited scleroderma, CREST, or diffuse scleroderma—can cause lung problems which may include aspiration pneumonia, lung abscesses, pleural effusions, pulmonary fibrosis, pulmonary hypertension and shrinking lung syndrome.
Approximately 4% of those with localized scleroderma (such as morphea or linear or en coup de sabre) may develop respiratory symptoms, primarily restrictive pneumopathy.
Lung involvement of all types can occur alone, or as part of other illnesses, or, much less commonly, as a manifestation of scleroderma.
Unfortunately, systemic scleroderma is often not detected or diagnosed until the last stages of lung involvement, particularly in those who have not developed the overt and classic sign of scleroderma skin hardening, which is known as sclerodactyly. See ISN's free online PDF brochure "What is Scleroderma?" which includes a Systemic Scleroderma Symptom Checklist.)
Dysregulation of angiogenic homeostasis in systemic sclerosis (SSc). Increased serum endostatin is associated with skin sclerosis severity and pulmonary fibrosis and favors SSc disease progression. PubMed, International Journal of Rheumatic Diseases, 2 Jul 2013. (Also see: Common Medical Tests for Scleroderma and Prognosis)
Thoracic Manifestations of Connective Tissue Disease. The collagen vascular diseases that most commonly involve the lung are rheumatoid arthritis, progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and dermatomyositis, mixed connective tissue disease, and Sjögren syndrome. RadioGraphics, January 2012, pp. 32, 33-50.

Symptoms of Scleroderma Pulmonary Involvement

Scleroderma Lung-Associated Cough: More Than Meets the Eye? The loss of improvement in cough frequency in parallel with the loss of the physiologic benefit at 24 months suggests that cough may be more than just a nuisance symptom and may be related to inflammation and fibrosis. CHEST Journal, September 2012, Vol 142, No. 3.
Shortness of Breath This worrisome symptom has many acute and chronic causes. Follow this flowchart for more information about the diseases in which shortness of breath occurs. familydoctor.org
Chest Pain, Chronic Many different types of problems can cause discomfort, shortness of breath, pain with swallowing, and many other symptoms in the chest area. This chart may help you pinpoint your problem as you confirm your symptoms. familydoctor.org

Diagnosis of Scleroderma Pulmonary Involvement

Overview
Tests for Pulmonary Involvement
Diagnosis of Pulmonary Fibrosis
Diagnosis of Pulmonary Hypertension

Severity and Prognosis for Scleroderma Pulmonary Involvement

Overview
Predictors of Morbidity and Mortality
Health Related Quality of Life Issues (HRQOL)

Aspiration Pneumonia

Aspiration pneumonia occurs when vomitus or reflux gets into the lungs, causing an often deadly form of pneumonia. ISN.
Overview
Correlation with Lung Involvement
Diagnosis
Prevention
Personal Stories

Autoimmune Interstitial Pneumonia

Undifferentiated Connective Tissue Disease (UCTD) presenting with prevalent interstitial lung disease: case report and review of literature. The diagnosis of UCTD should be considered when NSIP (nonspecific interstitial pneumonia) is diagnosed even in cases with evident first clinical manifestations of severe respiratory dysfunction. Diagn Pathol. 2011 Jun 7. (Also see: UCTD)

Lung Cancer

Scleroderma and Cancer. Systemic sclerosis (scleroderma) may be associated with an increased incidence of cancer, including breast cancer, B-cell lymphoma, lung cancer and tongue cancer. ISN.
Overview
Angiosarcoma
Autoantibodies
Breast Cancer
Cervical Cancer
Gastrointestinal Tract Cancer
Lymphoma
Malignant Atrophic Papulosis/Degos
MALT Lymphoma
Non-Hodgkin's Lymphoma
Medications and Cancer
Liver Cancer
Lung Cancer
Melanoma
Myeloma (Bone Marrow Cancer)
T Cell Lymphoma
Tongue and Oral Cancer
Tumors
Personal Stories

Methotrexate and Pulmonary Complications

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Drug-induced interstitial lung disease (DILD) is not uncommon and has many clinical patterns, ranging from benign infiltrates to life-threatening acute respiratory distress syndrome. Respiratory Research 2012, 13:39. (Also see: Methotrexate)

Oxygen Therapy

Overview of Oxygen Therapy
Dangers of Oxygen and Flame
Custom Oxygen Tank Covers and Cases
Oxy View Glasses
Related Patient Stories

Pleural Effusion

Pleural Effusion is fluid in the lining of the lungs. In scleroderma, this is usually caused by inflammation (rather than infection.) ISN.
What is Pleural Effusion?
Treatments
Resources
Personal Stories

Pulmonary Fibrosis

Pulmonary (Lung) Fibrosis is a scarring of the lungs, and is the consequence of untreated pulmonary inflammation (alveolitis). ISN.
Overview of Pulmonary Fibrosis
Symptoms
Correlations
Diagnosis
Treatments
Research
Clinical Trials
Patient Stories
References

Pulmonary Hypertension

Pulmonary Hypertension (PH) is high blood pressure in the arteries which take blood between the heart and lungs. ISN.
What is PH?
Primary PH
Secondary PH
Exercised Induced PH
Causes of PH
Disease Correlations
Symptoms
Diagnosis
Prognosis
Treatments
Research Registries
Research
Patient Support
Personal Stories

Pulmonary Veno-Occlusive Disease

Pulmonary veno-occlusive disease is an extremely rare form of high blood pressure in the lung arteries. MedLine Plus.

Restrictive Lung Disease

Restrictive Lung Disease. Restrictive lung diseases are characterized by reduced lung volume, either because of an alteration in lung parenchyma or because of a disease of the pleura, chest wall, or neuromuscular apparatus. In physiological terms, restrictive lung diseases are characterized by reduced total lung capacity (TLC), vital capacity, or resting lung volume. eMedicine.

Shrinking Lung Syndrome

Shrinking lung syndrome and systemic autoimmune disease. Shrinking lung syndrome is rare but must be considered in patients with autoimmune disease and dyspnea. The diagnosis can be difficult because of clinical, pathological and functional features which are controversial. PubMed. Rev Med Interne.
 
Go to Aspiration Pneumonia
About the ISN

This website is certified by Health On the Net Foundation. Click to verify.We are a full-service nonprofit 501(c)(3) providing stellar worldwide research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. This site complies with the HONcode standard for trustworthy health information: verify here.

 

Scleroderma Hotline (English Only)
Toll Free U.S. Call 1-800-564-7099
Direct Line: Call U.S. 952-831-3091

Post a message in Sclero Forums
Email: isn@sclero.org

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States

AKA Scleroderma from A to Z and SCLERO.ORG
Privacy Policy, Financial Disclosure, and Disclaimer.

Home   Medical   News   Sclero Forums   Support   Translations

© Copyright 1998-2014 International Scleroderma Network
All Rights Reserved